Algernon Pharmaceuticals Inc (AGNPF)

[medchem]

Thanks to the other moderators for responding, quicker than I could.

What I will add to their responses:

There are two things going on here...

1) We have existing drug

2) We are making more drug

So, for point 1:

We have enough drug in hand that we can supply the Phase 2 trial in South korea

So, for point 2:

We hired a chemical company in the USA to not only make more Ifenprodil for us but also look into making it in a more streamlined fashion.

Additional point:

We are going to secure IP on a novel formulation for IV use.

The implications of this go beyond our trials. If others want to use it by IV, they will be going through us.